These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 25270354)

  • 21. LAU-0901, a novel platelet-activating factor antagonist, is highly neuroprotective in cerebral ischemia.
    Belayev L; Khoutorova L; Atkins K; Gordon WC; Alvarez-Builla J; Bazan NG
    Exp Neurol; 2008 Dec; 214(2):253-8. PubMed ID: 18793637
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bryostatin improves survival and reduces ischemic brain injury in aged rats after acute ischemic stroke.
    Tan Z; Turner RC; Leon RL; Li X; Hongpaisan J; Zheng W; Logsdon AF; Naser ZJ; Alkon DL; Rosen CL; Huber JD
    Stroke; 2013 Dec; 44(12):3490-7. PubMed ID: 24172582
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Extension of the neuroprotective time window for thiazolidinediones in ischemic stroke is dependent on time of reperfusion.
    Gamboa J; Blankenship DA; Niemi JP; Landreth GE; Karl M; Hilow E; Sundararajan S
    Neuroscience; 2010 Oct; 170(3):846-57. PubMed ID: 20691766
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Therapy with recombinant T-cell receptor ligand reduces infarct size and infiltrating inflammatory cells in brain after middle cerebral artery occlusion in mice.
    Dziennis S; Mader S; Akiyoshi K; Ren X; Ayala P; Burrows GG; Vandenbark AA; Herson PS; Hurn PD; Offner HA
    Metab Brain Dis; 2011 Jun; 26(2):123-33. PubMed ID: 21472429
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A novel HLA-DRα1-MOG-35-55 construct treats experimental stroke.
    Benedek G; Zhu W; Libal N; Casper A; Yu X; Meza-Romero R; Vandenbark AA; Alkayed NJ; Offner H
    Metab Brain Dis; 2014 Mar; 29(1):37-45. PubMed ID: 24122483
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intranasal delivery of progesterone after transient ischemic stroke decreases mortality and provides neuroprotection.
    Fréchou M; Zhang S; Liere P; Delespierre B; Soyed N; Pianos A; Schumacher M; Mattern C; Guennoun R
    Neuropharmacology; 2015 Oct; 97():394-403. PubMed ID: 26079443
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ruscogenin reduces cerebral ischemic injury via NF-κB-mediated inflammatory pathway in the mouse model of experimental stroke.
    Guan T; Liu Q; Qian Y; Yang H; Kong J; Kou J; Yu B
    Eur J Pharmacol; 2013 Aug; 714(1-3):303-11. PubMed ID: 23911884
    [TBL] [Abstract][Full Text] [Related]  

  • 28. HAMI 3379, a CysLT2R antagonist, dose- and time-dependently attenuates brain injury and inhibits microglial inflammation after focal cerebral ischemia in rats.
    Shi QJ; Wang H; Liu ZX; Fang SH; Song XM; Lu YB; Zhang WP; Sa XY; Ying HZ; Wei EQ
    Neuroscience; 2015 Apr; 291():53-69. PubMed ID: 25681271
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment with afobazole at delayed time points following ischemic stroke improves long-term functional and histological outcomes.
    Katnik C; Garcia A; Behensky AA; Yasny IE; Shuster AM; Seredenin SB; Petrov AV; Seifu S; McAleer J; Willing A; Cuevas J
    Neurobiol Dis; 2014 Feb; 62():354-64. PubMed ID: 24141021
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nasal vaccination with myelin oligodendrocyte glycoprotein reduces stroke size by inducing IL-10-producing CD4+ T cells.
    Frenkel D; Huang Z; Maron R; Koldzic DN; Hancock WW; Moskowitz MA; Weiner HL
    J Immunol; 2003 Dec; 171(12):6549-55. PubMed ID: 14662856
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Extended therapeutic window and functional recovery after intraarterial administration of neuregulin-1 after focal ischemic stroke.
    Xu Z; Croslan DR; Harris AE; Ford GD; Ford BD
    J Cereb Blood Flow Metab; 2006 Apr; 26(4):527-35. PubMed ID: 16136057
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neuroprotective profile of enoxaparin, a low molecular weight heparin, in in vivo models of cerebral ischemia or traumatic brain injury in rats: a review.
    Stutzmann JM; Mary V; Wahl F; Grosjean-Piot O; Uzan A; Pratt J
    CNS Drug Rev; 2002; 8(1):1-30. PubMed ID: 12070524
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Xuesaitong May Protect Against Ischemic Stroke by Modulating Microglial Phenotypes and Inhibiting Neuronal Cell Apoptosis via the STAT3 Signaling Pathway.
    Li F; Zhao H; Han Z; Wang R; Tao Z; Fan Z; Zhang S; Li G; Chen Z; Luo Y
    CNS Neurol Disord Drug Targets; 2019; 18(2):115-123. PubMed ID: 30426907
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Early Treatment with Poly(ADP-Ribose) Polymerase-1 Inhibitor (JPI-289) Reduces Infarct Volume and Improves Long-Term Behavior in an Animal Model of Ischemic Stroke.
    Kim Y; Kim YS; Kim HY; Noh MY; Kim JY; Lee YJ; Kim J; Park J; Kim SH
    Mol Neurobiol; 2018 Sep; 55(9):7153-7163. PubMed ID: 29383691
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment of rats with pioglitazone in the reperfusion phase of focal cerebral ischemia: a preclinical stroke trial.
    Culman J; Nguyen-Ngoc M; Glatz T; Gohlke P; Herdegen T; Zhao Y
    Exp Neurol; 2012 Dec; 238(2):243-53. PubMed ID: 22995601
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Partial MHC Constructs Treat Thromboembolic Ischemic Stroke Characterized by Early Immune Expansion.
    Dotson AL; Chen Y; Zhu W; Libal N; Alkayed NJ; Offner H
    Transl Stroke Res; 2016 Feb; 7(1):70-8. PubMed ID: 26627498
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intranasal Delivery of Apelin-13 Is Neuroprotective and Promotes Angiogenesis After Ischemic Stroke in Mice.
    Chen D; Lee J; Gu X; Wei L; Yu SP
    ASN Neuro; 2015; 7(5):. PubMed ID: 26391329
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of nicorandil on the spatial arrangement of primary motor cortical neurons in the sub-acute phase of stroke in a rat model.
    Owjfard M; Taghadosi Z; Bigdeli MR; Safari A; Zarifkar A; Borhani-Haghighi A; Namavar MR
    J Chem Neuroanat; 2021 Nov; 117():102000. PubMed ID: 34233211
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Spatio-temporal assessment of the neuroprotective effects of neuregulin-1 on ischemic stroke lesions using MRI.
    Wang S; Li Y; Paudyal R; Ford BD; Zhang X
    J Neurol Sci; 2015 Oct; 357(1-2):28-34. PubMed ID: 26183085
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The novel exercise-induced hormone irisin protects against neuronal injury via activation of the Akt and ERK1/2 signaling pathways and contributes to the neuroprotection of physical exercise in cerebral ischemia.
    Li DJ; Li YH; Yuan HB; Qu LF; Wang P
    Metabolism; 2017 Mar; 68():31-42. PubMed ID: 28183451
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.